期刊文献+

复方托品酰胺对不同年龄段低度近视人员验光结果的影响 被引量:2

Cycloplegic effects of 0. 5g / L tropicamide in various low myopia age groups
下载PDF
导出
摘要 目的:观察复方托品酰胺滴眼液对不同年龄近视患者的屈光检查、睫状肌麻痹效果的影响,探究睫状肌麻痹对低度近视验光结果的影响,为临床患者合理使用散瞳药物提出指导。 方法:分别选取三个年龄段低度近视患者45例,在自然瞳孔状态下及散瞳后不同时间点使用“Shin-Nippon”开放式电脑验光仪测量双眼屈光度及调节幅度。 结果:各年龄组在使用散瞳剂后在20~60 min区间均出现明显调节幅度下降趋势,但调节幅度的下降与散瞳前后的“Shin-Nippon”开放式电脑验光结果无统计学意义。 结论:我们应根据调节幅度随着散瞳后不同时间的变化规律安排好患者的验光窗口,而针对低度近视人群,使用开放式电脑验光仪可以有效减少睫状肌麻痹剂的使用。 AlM: To investigated the refraction and cycloplegic effects of 0. 5g/L tropicamide eye drops in various low myopia age groups, and provide clinical guidelines for proper usage of cyclopegic agent in different population.METHODS:Three low myopia age groups (n=45) were selected, non-cycloplegic and cycloplegic auto-refraction using “Shin-Nippon” auto-refractor were performed at various time point for refractive error. The subjective accommodation amplitudes were also collected at each time point. RESULTS: The accommodation amplitude showed a similar but significant decline between 20~60min after the first cyclopegic drops in all three age groups. However, the decline of accommodation amplitudes were not statistically correlated with the results of “Shin-Nippon”auto-refraction results at different time points. CONCLUSlON: The refraction time should be arranged according to the cycloplegic effects of tropicamide. Open-field auto-refractor could reduce the usage of cycloglegice drugs in low myopia groups, even for the youngest.
出处 《国际眼科杂志》 CAS 2014年第12期2295-2296,共2页 International Eye Science
基金 广州市科信局科技攻关项目(No.201300000182)~~
关键词 托品酰胺 低度近视 屈光检查 睫状肌麻痹 tropicamide low myopia objective refraction cycloplegia
  • 相关文献

参考文献5

二级参考文献24

  • 1亢晓丽,杨积文,马鹤.假性近视71例分析[J].中国斜视与小儿眼科杂志,2004,12(2):58-61. 被引量:15
  • 2蒋丽琴,吕帆,周翔天,赵海岚,王瑞卿,瞿佳.环戊通松弛豚鼠睫状肌的调节作用[J].眼视光学杂志,2004,6(4):203-205. 被引量:9
  • 3肖激文.实用护理药物学[M].北京:人民军医出版社.2007.770.
  • 4徐广第.眼科视光学[M].第4版.北京:军事医学科学出版社,2005:66-68.
  • 5Saw SM,Gazzard G,et al.Myopia attempts to arrestprogression[J].BrJ Ophthalmol,2002,86(11):1306-1311.
  • 6Gordon DM,Ehrenberg MH. Cyclopentolate hydrochloride: A new mydriatic and cycloplegic agent; a pharmacologic and clinical evaluation[J]. Am J Ophthalmol,1954,38(6):831-838.
  • 7Schlossman A. An evaluation of a new cycloplegic:cyclopentolate[J]. Ear Nose Throat J,1956,35(2):126-127.
  • 8Thomas MC,Caissial C. Cycloplegia induced by cyclopentolate in the examination of refraction[J]. Bull Soc Ophthalmol Fr,1974,74(5-6):621-631.
  • 9Dutescu M,Muhl J. Refractometry after treating with atropine and cyclopentolate in childhood[J]. Klin Monatsbl Augenheilkd,1979,174(4):621-628.
  • 10Manny RE,Fern KD. 1% cyclopentolate hydrochloride: another look at the time course of cycloplegia using an objective measure of the accommodative response[J]. Optom Vis Sci,1993,70(8):651-665.

共引文献20

同被引文献23

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部